REWALK ROBOTICS LTD (RWLK)
IL0011331076 - Common Stock
Taking everything into account, RWLK scores 3 out of 10 in our fundamental rating. RWLK was compared to 195 industry peers in the Health Care Equipment & Supplies industry. The financial health of RWLK is average, but there are quite some concerns on its profitability. RWLK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RWLK has reported negative net income.
In the past year RWLK has reported a negative cash flow from operations.
RWLK had negative earnings in each of the past 5 years.
RWLK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
RWLK has a Return On Assets of -31.49%. This is comparable to the rest of the industry: RWLK outperforms 42.21% of its industry peers.
RWLK has a Return On Equity (-42.10%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.49% | ||
| ROE | -42.1% | ||
| ROIC | N/A |
ROA(3y)-28.68%
ROA(5y)-58.96%
ROE(3y)-34.19%
ROE(5y)-271.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RWLK's Gross Margin of 29.29% is on the low side compared to the rest of the industry. RWLK is outperformed by 73.37% of its industry peers.
RWLK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RWLK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-2.82%
2. Health
2.1 Basic Checks
RWLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
RWLK has less shares outstanding than it did 1 year ago.
The number of shares outstanding for RWLK has been increased compared to 5 years ago.
There is no outstanding debt for RWLK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
RWLK has an Altman-Z score of -2.88. This is a bad value and indicates that RWLK is not financially healthy and even has some risk of bankruptcy.
RWLK's Altman-Z score of -2.88 is on the low side compared to the rest of the industry. RWLK is outperformed by 64.82% of its industry peers.
There is no outstanding debt for RWLK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.88 |
ROIC/WACCN/A
WACC8.59%
2.3 Liquidity
RWLK has a Current Ratio of 3.47. This indicates that RWLK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.47, RWLK is in line with its industry, outperforming 53.27% of the companies in the same industry.
A Quick Ratio of 3.00 indicates that RWLK has no problem at all paying its short term obligations.
RWLK has a Quick ratio (3.00) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.47 | ||
| Quick Ratio | 3 |
3. Growth
3.1 Past
The earnings per share for RWLK have decreased strongly by -27.59% in the last year.
The Revenue has grown by 99.78% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.60% on average over the past years.
EPS 1Y (TTM)-27.59%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-44.44%
Revenue 1Y (TTM)99.78%
Revenue growth 3Y4.2%
Revenue growth 5Y-6.6%
Revenue growth Q2Q394.38%
3.2 Future
RWLK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.76% yearly.
RWLK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 65.46% yearly.
EPS Next Y-21.12%
EPS Next 2Y-8.6%
EPS Next 3Y4.45%
EPS Next 5Y8.76%
Revenue Next Year162.79%
Revenue Next 2Y147.47%
Revenue Next 3Y98.35%
Revenue Next 5Y65.46%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RWLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RWLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.6%
EPS Next 3Y4.45%
5. Dividend
5.1 Amount
No dividends for RWLK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
REWALK ROBOTICS LTD
NASDAQ:RWLK (1/29/2024, 7:00:03 PM)
After market: 1.0798 +0.03 (+2.83%)1.0501
+0.06 (+6.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap63.03M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.49% | ||
| ROE | -42.1% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.29% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.47 | ||
| Quick Ratio | 3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-27.59%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-21.12%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)99.78%
Revenue growth 3Y4.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y